These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

740 related items for PubMed ID: 15757595

  • 1. Impact of obesity on revascularization and restenosis rates after bare-metal and drug-eluting stent implantation (from the TAXUS-IV trial).
    Nikolsky E, Kosinski E, Mishkel GJ, Kimmelstiel C, McGarry TF, Mehran R, Leon MB, Russell ME, Ellis SG, Stone GW.
    Am J Cardiol; 2005 Mar 15; 95(6):709-15. PubMed ID: 15757595
    [Abstract] [Full Text] [Related]

  • 2. Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial.
    Stone GW, Ellis SG, O'Shaughnessy CD, Martin SL, Satler L, McGarry T, Turco MA, Kereiakes DJ, Kelley L, Popma JJ, Russell ME, TAXUS V ISR Investigators.
    JAMA; 2006 Mar 15; 295(11):1253-63. PubMed ID: 16531618
    [Abstract] [Full Text] [Related]

  • 3. Long-Term Results of Everolimus-Eluting Stents Versus Drug-Eluting Balloons in Patients With Bare-Metal In-Stent Restenosis: 3-Year Follow-Up of the RIBS V Clinical Trial.
    Alfonso F, Pérez-Vizcayno MJ, García Del Blanco B, Otaegui I, Masotti M, Zueco J, Veláquez M, Sanchís J, García-Touchard A, Lázaro-García R, Moreu J, Bethencourt A, Cuesta J, Rivero F, Cárdenas A, Gonzalo N, Jiménez-Quevedo P, Fernández C, RIBS V Study Investigators.
    JACC Cardiovasc Interv; 2016 Jun 27; 9(12):1246-1255. PubMed ID: 27339840
    [Abstract] [Full Text] [Related]

  • 4. A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent-in-stent restenosis: the RIBS V Clinical Trial (Restenosis Intra-stent of Bare Metal Stents: paclitaxel-eluting balloon vs. everolimus-eluting stent).
    Alfonso F, Pérez-Vizcayno MJ, Cárdenas A, García Del Blanco B, Seidelberger B, Iñiguez A, Gómez-Recio M, Masotti M, Velázquez MT, Sanchís J, García-Touchard A, Zueco J, Bethencourt A, Melgares R, Cequier A, Dominguez A, Mainar V, López-Mínguez JR, Moreu J, Martí V, Moreno R, Jiménez-Quevedo P, Gonzalo N, Fernández C, Macaya C, RIBS V Study Investigators, under the auspices of the Working Group on Interventional Cardiology of the Spanish Society of Cardiology.
    J Am Coll Cardiol; 2014 Apr 15; 63(14):1378-86. PubMed ID: 24412457
    [Abstract] [Full Text] [Related]

  • 5. Outcomes with the paclitaxel-eluting stent in patients with acute coronary syndromes: analysis from the TAXUS-IV trial.
    Moses JW, Mehran R, Nikolsky E, Lasala JM, Corey W, Albin G, Hirsch C, Leon MB, Russell ME, Ellis SG, Stone GW.
    J Am Coll Cardiol; 2005 Apr 19; 45(8):1165-71. PubMed ID: 15837244
    [Abstract] [Full Text] [Related]

  • 6. Comparison of the slow-release polymer-based paclitaxel-eluting Taxus-Express stent with the bare-metal Express stent for saphenous vein graft interventions.
    Wöhrle J, Nusser T, Kestler HA, Kochs M, Hombach V.
    Clin Res Cardiol; 2007 Feb 19; 96(2):70-6. PubMed ID: 17146605
    [Abstract] [Full Text] [Related]

  • 7. Outcomes of paclitaxel-eluting stent implantation in patients with stenosis of the left anterior descending coronary artery.
    Dangas G, Ellis SG, Shlofmitz R, Katz S, Fish D, Martin S, Mehran R, Russell ME, Stone GW, TAXUS-IV Investigators.
    J Am Coll Cardiol; 2005 Apr 19; 45(8):1186-92. PubMed ID: 15837247
    [Abstract] [Full Text] [Related]

  • 8. Influence of stent length to lesion length ratio on angiographic and clinical outcomes after implantation of bare metal and drug-eluting stents (the TAXUS-IV Study).
    Wong SC, Hong MK, Ellis SG, Buchbinder M, Reisman M, DeLago A, Kellett M, Popma JJ, Russell ME, Mehran R, Moses JW, Stone GW.
    Am J Cardiol; 2005 May 01; 95(9):1043-8. PubMed ID: 15842968
    [Abstract] [Full Text] [Related]

  • 9. Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial.
    Stone GW, Ellis SG, Cannon L, Mann JT, Greenberg JD, Spriggs D, O'Shaughnessy CD, DeMaio S, Hall P, Popma JJ, Koglin J, Russell ME, TAXUS V Investigators.
    JAMA; 2005 Sep 14; 294(10):1215-23. PubMed ID: 16160130
    [Abstract] [Full Text] [Related]

  • 10. Gender-based outcomes after paclitaxel-eluting stent implantation in patients with coronary artery disease.
    Lansky AJ, Costa RA, Mooney M, Midei MG, Lui HK, Strickland W, Mehran R, Leon MB, Russell ME, Ellis SG, Stone GW, TAXUS-IV Investigators.
    J Am Coll Cardiol; 2005 Apr 19; 45(8):1180-5. PubMed ID: 15837246
    [Abstract] [Full Text] [Related]

  • 11. Impact of moderate renal insufficiency on restenosis and adverse clinical events after paclitaxel-eluting and bare metal stent implantation: results from the TAXUS-IV Trial.
    Halkin A, Mehran R, Casey CW, Gordon P, Matthews R, Wilson BH, Leon MB, Russell ME, Ellis SG, Stone GW.
    Am Heart J; 2005 Dec 19; 150(6):1163-70. PubMed ID: 16338253
    [Abstract] [Full Text] [Related]

  • 12. Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction.
    Stone GW, Lansky AJ, Pocock SJ, Gersh BJ, Dangas G, Wong SC, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, Möckel M, Ochala A, Kellock A, Parise H, Mehran R, HORIZONS-AMI Trial Investigators.
    N Engl J Med; 2009 May 07; 360(19):1946-59. PubMed ID: 19420364
    [Abstract] [Full Text] [Related]

  • 13. Outcomes with the polymer-based paclitaxel-eluting TAXUS stent in patients with diabetes mellitus: the TAXUS-IV trial.
    Hermiller JB, Raizner A, Cannon L, Gurbel PA, Kutcher MA, Wong SC, Russell ME, Ellis SG, Mehran R, Stone GW, TAXUS-IV Investigators.
    J Am Coll Cardiol; 2005 Apr 19; 45(8):1172-9. PubMed ID: 15837245
    [Abstract] [Full Text] [Related]

  • 14. Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial.
    Morice MC, Colombo A, Meier B, Serruys P, Tamburino C, Guagliumi G, Sousa E, Stoll HP, REALITY Trial Investigators.
    JAMA; 2006 Feb 22; 295(8):895-904. PubMed ID: 16493102
    [Abstract] [Full Text] [Related]

  • 15. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease.
    Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J, Popma JJ, Russell ME, TAXUS-IV Investigators.
    N Engl J Med; 2004 Jan 15; 350(3):221-31. PubMed ID: 14724301
    [Abstract] [Full Text] [Related]

  • 16. Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization.
    Windecker S, Remondino A, Eberli FR, Jüni P, Räber L, Wenaweser P, Togni M, Billinger M, Tüller D, Seiler C, Roffi M, Corti R, Sütsch G, Maier W, Lüscher T, Hess OM, Egger M, Meier B.
    N Engl J Med; 2005 Aug 18; 353(7):653-62. PubMed ID: 16105989
    [Abstract] [Full Text] [Related]

  • 17. One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial.
    Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J, Popma JJ, Russell ME, TAXUS-IV Investigators.
    Circulation; 2004 Apr 27; 109(16):1942-7. PubMed ID: 15078803
    [Abstract] [Full Text] [Related]

  • 18. Impact of platelet glycoprotein IIb/IIIa Inhibition on the paclitaxel-eluting stent in patients with stable or unstable angina pectoris or provocable myocardial ischemia (a TAXUS IV substudy).
    Teirstein PS, Kao J, Watkins M, Tannenbaum MA, Laufer N, Chang M, Mehran R, Dangas G, Russell ME, Ellis SG, Stone GW.
    Am J Cardiol; 2005 Aug 15; 96(4):500-5. PubMed ID: 16098300
    [Abstract] [Full Text] [Related]

  • 19. Impact of routine angiographic follow-up on the clinical benefits of paclitaxel-eluting stents: results from the TAXUS-IV trial.
    Pinto DS, Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, Mehran R, Na Y, Turco M, Caputo R, Popma JJ, Cutlip DE, Russell ME, Cohen DJ, TAXUS-IV Investigators.
    J Am Coll Cardiol; 2006 Jul 04; 48(1):32-6. PubMed ID: 16814645
    [Abstract] [Full Text] [Related]

  • 20. Long-term safety and efficacy with paclitaxel-eluting stents: 5-year final results of the TAXUS IV clinical trial (TAXUS IV-SR: Treatment of De Novo Coronary Disease Using a Single Paclitaxel-Eluting Stent).
    Ellis SG, Stone GW, Cox DA, Hermiller J, O'Shaughnessy C, Mann T, Turco M, Caputo R, Bergin PJ, Bowman TS, Baim DS, TAXUS IV Investigators.
    JACC Cardiovasc Interv; 2009 Dec 04; 2(12):1248-59. PubMed ID: 20129552
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.